Trevor Anderson
Immunotherapeutics & Biotechnology
 |
|
Biography
Trevor Anderson completed his Bachelor of Science (BS) degree in Biophysics from Brigham Young University, Provo, Utah in 2013, and his Master of Business Administration (MBA) in Health Organization Management (HOM) from Texas Tech University, Lubbock, in 2014. He completed his Master of Science (MS) degree in Biotechnology from the Ογ½ΆΦ±²₯ Graduate School of Biomedical Sciences, Abilene, in 2019, and joined the Graduate Program in Pharmaceutical Sciences as a Doctor of Philosophy (PhD) student in August of 2019. He is presently working in the laboratory of Dr. Devin Lowe with the Department of Immunotherapeutics and Biotechnology in Abilene.
Education:
- MS: Biotechnology, Ογ½ΆΦ±²₯ GSBS, Abilene, 2019
- MBA: TTU Rawls College of Business, Lubbock, 2014
- BS: Biophysics, Brigham Young University, Provo, Utah, 2013
Research Interests:
Cancer Immunology, Protein Engineering, Tumor Angiogenesis.
Publications:
Before Admission to GPPS:
- Wooster AL, Anderson TS, Lowe DB. Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines. J Immunol Methods. 2019 Jan;464:22-30. Epub 2018 Oct 19.
After Admission to GPPS:
- Anderson TS, Wooster AL, Piersall SL, Okpalanwaka IF, Lowe DB. Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity. Semin Cancer Biol. 2022 Nov; 86(Pt 3):981-996. Epub 2022 Feb 8.
- Anderson TS, Wooster AL, La-Beck NM, Saha D, Lowe DB. Antibody-drug conjugates: an evolving approach for melanoma treatment. Melanoma Res. 2021 Feb 1;31(1):1-17.
- Wooster AL, Girgis LH, Brazeale H, Anderson TS, Wood LM, Lowe DB. Dendritic cell vaccine therapy for colorectal cancer. Pharmacol Res. 2021 Feb;164:105374. Epub 2020 Dec 28.
- Anderson TS, Wooster AL, La-Beck NM, Saha D, Lowe DB. Antibody-drug conjugates: an evolving approach for melanoma treatment. Melanoma Res. 2020 Nov 6. Epub ahead of print.
Presentations:
Before Admission to GPPS:
- Wooster AL, Anderson TS, Lowe DB. βExpression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines.β Student Research Week, Ογ½ΆΦ±²₯ Graduate School in Biomedical Sciences (GSBS), Lubbock, TX; March 2019. [presented by Anderson TS]
After Admission to GPPS:
- Anderson TS, Wooster AL, Oladejo M, Wood LM, Lowe DB. "Listeria Monocytogenes-Based Vaccines to Mediate Targeted Ablation of the Tumor-Associated Vasculature in Colorectal Cancer". American Association for Cancer Research (AACR) Special Conference, Boston, Massachusetts; October 2022.
- Trevor S. Anderson, Amanda L. Wooster, Mariam Oladejo, Laurence M. Wood, Devin B. Lowe. "Listeria monocytogenes-based vaccines to mediate targeted ablation of the tumor-associated vasculature in colorectal cancer". 19th Annual Research Days, Ογ½ΆΦ±²₯ Jerry H Hodge School of Pharmacy, Office of Sciences, in Amarillo, event at Lubbock, TX; June 2022.
Seminars:
- 02/24/2023 "Unleashing Granzyme B: A Retrospective in Antibody Fusion Protein Development"
- 09/10/2021 "Development of a Cytotoxic and Conditionally Active Biologic for HER2+ Cancer" [Oral Qualifying Exam, public presentation counted as Seminar credit]
- 04/23/2021 "Listeria-Based Vaccine Therapy for Colon Cancer Vascularization"
- 12/04/2020 "Exploring the use of Granzyme-B fusion proteins to model potential antibody-drug conjugate candidates"
Awards/Scholarships:
Before Admission to GPPS:
- Office of Research and Creative Activities (ORCA) Grant, 2012.
Memberships:
- Immunotherapeutics and Biotechnology Graduate Student Association (IBGSA), Ογ½ΆΦ±²₯ β Communications Officer, 2020-2021.
- Immunotherapeutics and Biotechnology Graduate Student Association (IBGSA), Ογ½ΆΦ±²₯, 2019-present.
- American Association of Immunologists, 2019-present.
- Society for Immunotherapy of Cancer, 2019-present.
- American Association for Cancer Research, 2019-present.